{"id":25429,"date":"2014-06-11T09:28:15","date_gmt":"2014-06-11T13:28:15","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=25429"},"modified":"2014-06-11T09:28:15","modified_gmt":"2014-06-11T13:28:15","slug":"merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429","title":{"rendered":"Merck &#038; Co.  Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/11\/2014 (wallstreetpr) \u2013 Merck &amp; Co. agreed to buy <b>Idenix Pharmaceuticals Inc (NASDAQ:IDIX)<\/b> in a deal worth $3.85 billion. Merck has agreed to buy the Pharma company for $24.50 a share in cash. The extra premium agreed for the deal was based on the competitive process of bidding.<\/p>\n<p style=\"text-align: justify;\"><b>Idenix Pharmaceuticals, Treatment of Hepatitis C and the Partnership between the companies<\/b><\/p>\n<p style=\"text-align: justify;\">Hepatitis C is the liver-damaging virus and it is estimated that it affects approximately 150 million people across the word. New medicines in this regard lead to better results and fewer side effects in comparison to older drugs. The newer medicines have shorter duration of the treatment. Idenix, which has around 85 employees with no products in market, registered less than $1 million revenue in the year 2013. However, the company developed a lot of potential new treatments for this virus and this has attracted a lot of big drug companies.<\/p>\n<p style=\"text-align: justify;\"><b>Merck\u2019s plans after acquisition<\/b><\/p>\n<p style=\"text-align: justify;\">Merck is mainly interested in the Idenix drug, IDX21437, which is known as Nuke or nucleotide. The company plans that after acquisition, it will combine this drug with its own drugs which work via different mechanisms. Two of the drugs developed by Merck will be used along with Idenix drug for triple-drug regimen. Though this triple-drug regimen is three years away, but once the clinical trials as well as approval from the regulators is finalised, it will prove to be very successful. However,Idenix Pharmaceuticals Inc (NASDAQ:IDIX)plans that first double-drug regimen should be brought to the market.<\/p>\n<p style=\"text-align: justify;\"><b>Statement from the Chief of Merck&#8217;s Research-And-Development Unit<\/b><\/p>\n<p style=\"text-align: justify;\">The Chief of Merck&#8217;s Research-And-Development Unit, Roger Perlmutter said that the goal of the company was everyone\u2019s treatment. He said that the company had plans of developing its own Nuke for this virus, but the program will receive a jump start through the deal with IIdenix Pharmaceuticals Inc (NASDAQ:IDIX).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/11\/2014 (wallstreetpr) \u2013 Merck &amp; Co. agreed to buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) in a deal worth $3.85 billion. Merck has agreed to [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":25432,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[1945,1946],"stock_ticker":[],"class_list":["post-25429","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-idenix-pharmaceuticals-inc-nasdaqidix","tag-nasdaqidix","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck &amp; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck &amp; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/11\/2014 (wallstreetpr) \u2013 Merck &amp; Co. agreed to buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) in a deal worth $3.85 billion. Merck has agreed to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-11T13:28:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"356\" \/>\n\t<meta property=\"og:image:height\" content=\"90\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Merck &#038; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal\",\"datePublished\":\"2014-06-11T13:28:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\"},\"wordCount\":323,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg\",\"keywords\":[\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX)\",\"NASDAQ:IDIX\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\",\"name\":\"Merck & Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg\",\"datePublished\":\"2014-06-11T13:28:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg\",\"width\":356,\"height\":90},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck &#038; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck & Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429","og_locale":"en_US","og_type":"article","og_title":"Merck & Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR","og_description":"Boston, MA 06\/11\/2014 (wallstreetpr) \u2013 Merck &amp; Co. agreed to buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) in a deal worth $3.85 billion. Merck has agreed to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-11T13:28:15+00:00","og_image":[{"width":356,"height":90,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Merck &#038; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal","datePublished":"2014-06-11T13:28:15+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429"},"wordCount":323,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg","keywords":["Idenix Pharmaceuticals Inc (NASDAQ:IDIX)","NASDAQ:IDIX"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429","url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429","name":"Merck & Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg","datePublished":"2014-06-11T13:28:15+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/index7.jpg","width":356,"height":90},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-agreed-to-buy-idenix-pharmaceuticals-inc-nasdaqidix-in-a-3-85-billion-deal-25429#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Merck &#038; Co. Agreed To Buy Idenix Pharmaceuticals Inc (NASDAQ:IDIX) In A $3.85 Billion Deal"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/25429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=25429"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/25429\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/25432"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=25429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=25429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=25429"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=25429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}